Biosimilar and Interchangeable Biosimilar Products: Considerations for Container Closure Systems and Device Constituent Parts; Draft Guidance for Industry; Availability
The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a draft guid...
Publisher
USA
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Federal Register
- Region
- USA
- Scope
- Regulatory
- Published
- August 3, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a draft guid...
Source route
Continue on federalregister.gov
Leave the platform to read the original full article on the publisher site.
Source: Federal Register
Scope: Regulatory
Related coverage
More related coverage
Pneumococcal polysaccharide conjugate vaccine (PCV20) PGD template
Patient group direction (PGD) template to support the provision of pneumococcal polysaccharide conju...
PCV (13-valent or 15-valent, adsorbed): patient group direction (PGD) template
PGD template to support the national pneumococcal polysaccharide conjugate vaccine (13-valent or 15-...
DHSC privacy notice
Find out about DHSC's data protection policy and procedures.
Department of Health and Social Care record of processing activity (RoPA)
The record of processing activity lists the personal data being held and processed by the Department...